TECH vs WEX · P/E 65, rev $1.22B vs P/E 14, rev $2.63B
Bio-Techne Corp (TECH) versus Wex Inc (WEX) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Wex Inc (WEX) is a software - infrastructure company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported WEX revenue for 2024-12-31 was $2.63B. Net income was $309.6M. Revenue was up 3.1% from 2023-12-31 to 2024-12-31. WEX currently screens at market cap $4.40B and trailing P/E 14.3.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. WEX currently screens at market cap $4.40B and trailing P/E 14.3.
Not investment advice. Open the TECH and WEX stock pages for the full models.
Not investment advice.